Pure speculation but it is possible that AMRNs drug Vascepa might cause its CVS effects by epigenetic mechanisms. It affects a broad spectrum of antiiflamatory and other markers and its antimitotic effects are now known to be due to epigenetic change as a result of DNA methylation. Betonmace appears more specific and if vascepa can lower Mace by 25%, hopefully betonmace can do better.